GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xtant Medical Holdings Inc (AMEX:XTNT) » Definitions » Piotroski F-Score

Xtant Medical Holdings (Xtant Medical Holdings) Piotroski F-Score : 4 (As of Apr. 25, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Xtant Medical Holdings Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Xtant Medical Holdings has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Xtant Medical Holdings's Piotroski F-Score or its related term are showing as below:

XTNT' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 6
Current: 4

During the past 13 years, the highest Piotroski F-Score of Xtant Medical Holdings was 6. The lowest was 1. And the median was 4.


Xtant Medical Holdings Piotroski F-Score Historical Data

The historical data trend for Xtant Medical Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xtant Medical Holdings Piotroski F-Score Chart

Xtant Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 3.00 5.00 2.00 4.00

Xtant Medical Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 2.00 2.00 4.00 4.00

Competitive Comparison of Xtant Medical Holdings's Piotroski F-Score

For the Medical Devices subindustry, Xtant Medical Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -2.078 + -2.19 + 9.231 + -4.303 = $0.66 Mil.
Cash Flow from Operations was -2.245 + -2.521 + -3.834 + -0.915 = $-9.52 Mil.
Revenue was 17.943 + 20.232 + 25.019 + 28.108 = $91.30 Mil.
Gross Profit was 10.536 + 12.459 + 15.334 + 17.137 = $55.47 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(60.229 + 63.316 + 65.218 + 92.003 + 92.612) / 5 = $74.6756 Mil.
Total Assets at the begining of this year (Dec22) was $60.23 Mil.
Long-Term Debt & Capital Lease Obligation was $18.04 Mil.
Total Current Assets was $64.87 Mil.
Total Current Liabilities was $22.99 Mil.
Net Income was -2.213 + -1.71 + -2.353 + -2.209 = $-8.49 Mil.

Revenue was 12.959 + 15.277 + 14.462 + 15.27 = $57.97 Mil.
Gross Profit was 7.56 + 8.374 + 7.896 + 8.306 = $32.14 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(54.692 + 53.17 + 52.713 + 56.049 + 60.229) / 5 = $55.3706 Mil.
Total Assets at the begining of last year (Dec21) was $54.69 Mil.
Long-Term Debt & Capital Lease Obligation was $10.84 Mil.
Total Current Assets was $49.32 Mil.
Total Current Liabilities was $15.22 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Xtant Medical Holdings's current Net Income (TTM) was 0.66. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Xtant Medical Holdings's current Cash Flow from Operations (TTM) was -9.52. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=0.66/60.229
=0.01095818

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-8.485/54.692
=-0.15514152

Xtant Medical Holdings's return on assets of this year was 0.01095818. Xtant Medical Holdings's return on assets of last year was -0.15514152. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Xtant Medical Holdings's current Net Income (TTM) was 0.66. Xtant Medical Holdings's current Cash Flow from Operations (TTM) was -9.52. ==> -9.52 <= 0.66 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=18.042/74.6756
=0.24160502

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=10.84/55.3706
=0.19577176

Xtant Medical Holdings's gearing of this year was 0.24160502. Xtant Medical Holdings's gearing of last year was 0.19577176. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=64.869/22.99
=2.82161809

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=49.318/15.218
=3.24076751

Xtant Medical Holdings's current ratio of this year was 2.82161809. Xtant Medical Holdings's current ratio of last year was 3.24076751. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Xtant Medical Holdings's number of shares in issue this year was 135.676. Xtant Medical Holdings's number of shares in issue last year was 108.63. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=55.466/91.302
=0.60750038

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=32.136/57.968
=0.55437483

Xtant Medical Holdings's gross margin of this year was 0.60750038. Xtant Medical Holdings's gross margin of last year was 0.55437483. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=91.302/60.229
=1.51591426

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=57.968/54.692
=1.05989907

Xtant Medical Holdings's asset turnover of this year was 1.51591426. Xtant Medical Holdings's asset turnover of last year was 1.05989907. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+1+0+0+0+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Xtant Medical Holdings has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Xtant Medical Holdings  (AMEX:XTNT) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Xtant Medical Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Xtant Medical Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Xtant Medical Holdings (Xtant Medical Holdings) Business Description

Traded in Other Exchanges
Address
664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
Executives
Kevin D Brandt officer: VP & Chief Commercial Officer 11621 RESEARCH CIRCLE, ALACHUA FL 32615
Lori D Mitchell-keller director 664 CRUISER LANE, BELGRADE MT 59714
Jonn R. Beeson director 664 CRUISER LANE, BELGRADE MT 59714
Scott C Neils officer: Interim CFO 664 CRUISER LANE, BELGRADE MT 59714
Mark A. Schallenberger officer: Chief Operations Officer 664 CRUISER LANE, BELGRADE MT 59714
Sean E Browne officer: President and CEO 664 CRUISER LANE, BELGRADE MT 59714
Stavros G. Vizirgianakis director 1/16-18 TENNYSON ST., WILLIAMSTOWN NORTH, VICTORIA CA 3016
Orbimed Rof Ii Llc director, 10 percent owner 601 LEXINGTON AVE., 54TH FLOOR, NEW YORK NY 10022
Greg Jensen officer: VP, Finance and Interim CFO 664 CRUISER LANE, BELGRADE MT 59714
Ronald G. Berlin officer: VP & Chief Operations Officer 664 CRUISER LANE, BELGRADE MT 59714
Kathie J. Lenzen officer: SVP Fiance & Admin. & CFO 664 CRUISER LANE, BELGRADE MT 59714
Orbimed Advisors Llc 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Matthew Rizzo director, 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Michael Eggenberg director, 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Robert Mcnamara director C/O LDR HOLDING CORPORATION, 13785 RESEARCH BOULEVARD, SUITE 200, AUSTIN TX 78750

Xtant Medical Holdings (Xtant Medical Holdings) Headlines

From GuruFocus